Chemino Pharma Limited - Due diligence report

A 360° intelligence report on Chemino Pharma Limited: trust score, financial health, credit view, compliance, directors, growth and distress…

2018-08-29 Mumbai, Maharashtra Active Unlisted Active Compliant
Share
Connect MCP
CP Chemino Pharma Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Chemino Pharma Limited — 360° Intelligence Report

Generated from MCA filings & public records
83/100
Trust Score
Low Risk

Chemino Pharma Limited is assessed as Low Risk with a Trust Score of 83/100. Chemino Pharma Limited is an active public limited indian non-government company incorporated in 2018, operating in the Pharma sector. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.

Report generated on 31 Jul 2026 from the latest processed filings. Chemino Pharma Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
83/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
93/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
70/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
30/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
85/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
80/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 30/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.
  • Open charges exceed net worth - secured lenders rank ahead.
  • Elevated gearing (D/E 38%).
  • Profitable - internal accruals available.

Charges position: 5 open (97.19 cr) · 1 satisfied (35.00 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Others5 48.0 cr
Hdfc Bank Limited1 48.0 cr
Compliance Score: 93/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Litigation present in 1 court forum(s).
  • 3 active GST registration(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 85/100
NameDIN / PANDesignationAppointedTenureDIN status
KIRAN PARMANAND GOKLANI 01234567 Director 01/04/2018 6 yrs Approved
SHRIRAJ SADASHIV SHETTY 01234567 Director 01/04/2018 6 yrs Approved
KANGANA VIVEKKUMAR RAMANI 01234567 Director 01/04/2018 6 yrs Approved
Chandan Dashrathsingh Rajpurohit 01234567 Director 01/04/2018 6 yrs Approved
MEGHRAJ DODDANNA SHETTY 01234567 Director 01/04/2018 6 yrs Approved
SADASHIV KANYANA SHETTY 01234567 Director 01/04/2018 6 yrs Approved
SHREYA SADASHIV SHETTY 01234567 Director 01/04/2018 6 yrs Approved
Nitin Suresh Belose 01234567 Director 01/04/2018 6 yrs Approved
  • 8 directors on the board.
  • No disqualified or deactivated DINs.
  • 3 director exit(s) in the last 3 years.
06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
1 allotment(s) · 2 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Key managerial personnel: SHRIRAJ SADASHIV SHETTY (Whole-time director) · SADASHIV KANYANA SHETTY (Managing Director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 80 · Distress 80
Growth signals & trust indicators
Latest year revenue grew 1.42.
Profit expanded 2.1x year-on-year.
Asset base grew 24% - capacity expansion.
EPFO headcount growing - hiring signal.
Operating for 7 years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Outside liabilities up 0.86 in a year.
5 open charge(s) registered - assets are encumbered.
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence86/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment58/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 5 open charge(s) of 97.19 cr already registered.
  • Compliance record supports lending.
Investor view77/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 4 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2025
Last AGM held
Annual general meeting
29 Sep 2025
Director ceased
KIRAN PARMANAND GOKLANI
Director ceased
Chandan Dashrathsingh Rajpurohit
18 Sep 2025
Charge created
Others - 1.46 cr
31 Mar 2025
Latest balance sheet
Filed with ROC
20 Mar 2025
Director appointed
Chandan Dashrathsingh Rajpurohit (Director)
20 Feb 2025
Director appointed
KIRAN PARMANAND GOKLANI (Director)
09 Jan 2025
Director appointed
Nitin Suresh Belose (Cfo)
28 Mar 2024
Charge created
Others - 87.00 Lakh
Charge created
Others - 9.13 cr
29 Sep 2023
Director ceased
MEGHRAJ DODDANNA SHETTY
01 Apr 2023
Director appointed
MEGHRAJ DODDANNA SHETTY (Director)
16 Mar 2023
Director ceased
SHRIRAJ SADASHIV SHETTY
Director ceased
SADASHIV KANYANA SHETTY
25 Oct 2022
Charge created
Hdfc Bank Limited - 72.93 Lakh
10

Key Observations

Auto-generated from the data above
Debt-to-equity stands at 61% - leverage worth monitoring.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
8 active director(s) / partner(s); board looks stable and experienced.
3 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Carbure Activated Carbon Private Limited U36990TZ2020PTC033630 Coimbatore South, Tamil Nadu, India
Golden Cashew Products Private Limited U74900PY2010PTC002408 Pondicherry, Pondicherry, India
Setcochemicals U26933MH1985PTC036470 Mumbai, Maharashtra, India
Agog Pharma Limited U24230MH1990PLC059515 Mumbai, Maharashtra, India
Savorite Pharma U33125GJ2019PTC105923 Vadodara, Gujarat, India
Resipol Adhesives Private Limited U24295GJ2013PTC077980 Kadi, Gujarat, India
Ascent Finechem U24231GJ1993PTC019297 Ahmadabad City, Gujarat, India
Mirash Industries Private Limited U24110GJ2016PTC094058 Bharuch, Gujarat, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Chemino Pharma Limited before audits and certifications: compliance score 93/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Chemino Pharma Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 30/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 80/100, margin trends, ownership structure and peer set for Chemino Pharma Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 83/100, distress signals and MSME payment-delay disclosures - know whether Chemino Pharma Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Chemino Pharma Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Chemino Pharma Limited an active company?

Chemino Pharma Limited has MCA status “Active” with a compliance score of 93/100 (Low Risk).

Is Chemino Pharma Limited financially healthy?

Chemino Pharma Limited has a Financial Health Score of 70/100 (Moderate) based on its filed financial statements.

Should I do business with Chemino Pharma Limited?

Its overall Trust Score is 83/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Chemino Pharma Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 8 active director(s) are on record.

Does Chemino Pharma Limited have loans or charges against its assets?

5 open charge(s) are registered against its assets, and 1 earlier charge(s) stand satisfied.

Is Chemino Pharma Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 93/100 (Low Risk).

Is it risky to lend to Chemino Pharma Limited?

Its Credit Risk Score is 30/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.